Immuron Ltd Cash Flow Conversion Efficiency

Latest as of December 2025: -0.189x

Immuron Ltd cash flow conversion efficiency. Based on the latest financial reports, Immuron Ltd (IMC) has a cash flow conversion efficiency ratio of -0.189x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-2.48 Million ≈ $-1.75 Million USD) by net assets (AU$13.08 Million ≈ $9.25 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Immuron Ltd (2001–2025)

Cash flow conversion efficiency of Immuron Ltd from 2001 to 2025. This chart illustrates how Immuron Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View latest Immuron Ltd stock price today for real-time trading data and today's change.

Immuron Ltd Cash Flow Conversion Ratio Explained

Immuron Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Immuron Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Immuron Ltd ranked by their cash flow conversion efficiency. Also see Immuron Ltd (IMC) market capitalisation for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Victoria Insurance Tbk PT
JK:VINS
-0.039x
BIG Industries Bhd
KLSE:7005
-0.028x
Federal International Holdings Bhd
KLSE:8605
-0.049x
Checkin.com Group AB
ST:CHECK
0.033x
Real Heart
ST:HEART
-0.026x
U-BX Technology Ltd.
NASDAQ:UBXG
-0.017x
Plascar Participações Industriais S.A
SA:PLAS3
-0.023x
LDT Inc
KQ:096870
0.027x

Annual Cash Flow Conversion Efficiency for Immuron Ltd (2001–2025)

The table below shows the annual cash flow conversion efficiency of Immuron Ltd from 2001 to 2025. Review IMC financial flexibility index to assess the company's free cash flow relative to its total liabilities.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-06-30 AU$8.07 Million
≈ $5.71 Million
AU$-6.14 Million
≈ $-4.34 Million
-0.761x -64.39%
2024-06-30 AU$12.71 Million
≈ $8.99 Million
AU$-5.88 Million
≈ $-4.16 Million
-0.463x -264.71%
2023-06-30 AU$19.62 Million
≈ $13.88 Million
AU$-2.49 Million
≈ $-1.76 Million
-0.127x +6.13%
2022-06-30 AU$23.18 Million
≈ $16.40 Million
AU$-3.13 Million
≈ $-2.22 Million
-0.135x +14.30%
2021-06-30 AU$25.90 Million
≈ $18.32 Million
AU$-4.08 Million
≈ $-2.89 Million
-0.158x +71.88%
2020-06-30 AU$5.64 Million
≈ $3.99 Million
AU$-3.16 Million
≈ $-2.24 Million
-0.561x -129.19%
2019-06-30 AU$7.35 Million
≈ $5.20 Million
AU$-1.80 Million
≈ $-1.27 Million
-0.245x +41.08%
2018-06-30 AU$8.44 Million
≈ $5.97 Million
AU$-3.50 Million
≈ $-2.48 Million
-0.415x +61.17%
2017-06-30 AU$6.57 Million
≈ $4.65 Million
AU$-7.03 Million
≈ $-4.97 Million
-1.069x -2.42%
2016-06-30 AU$4.94 Million
≈ $3.50 Million
AU$-5.16 Million
≈ $-3.65 Million
-1.044x -66.26%
2015-06-30 AU$4.81 Million
≈ $3.40 Million
AU$-3.02 Million
≈ $-2.14 Million
-0.628x -60.80%
2014-06-30 AU$6.79 Million
≈ $4.80 Million
AU$-2.65 Million
≈ $-1.88 Million
-0.391x +97.23%
2013-06-30 AU$144.99K
≈ $102.59K
AU$-2.05 Million
≈ $-1.45 Million
-14.108x -1074.35%
2012-06-30 AU$2.05 Million
≈ $1.45 Million
AU$-2.46 Million
≈ $-1.74 Million
-1.201x -5.67%
2011-06-30 AU$1.73 Million
≈ $1.23 Million
AU$-1.97 Million
≈ $-1.39 Million
-1.137x -69.19%
2010-06-30 AU$3.36 Million
≈ $2.38 Million
AU$-2.26 Million
≈ $-1.60 Million
-0.672x -105.99%
2009-06-30 AU$-184.87K
≈ $-130.81K
AU$-2.07 Million
≈ $-1.47 Million
11.209x +699.89%
2008-06-30 AU$1.11 Million
≈ $785.58K
AU$-2.07 Million
≈ $-1.47 Million
-1.868x -23.80%
2007-06-30 AU$1.98 Million
≈ $1.40 Million
AU$-2.99 Million
≈ $-2.12 Million
-1.509x -181.71%
2006-06-30 AU$5.24 Million
≈ $3.71 Million
AU$-2.81 Million
≈ $-1.99 Million
-0.536x -112.46%
2005-06-30 AU$6.96 Million
≈ $4.93 Million
AU$-1.76 Million
≈ $-1.24 Million
-0.252x +16.78%
2004-06-30 AU$4.08 Million
≈ $2.89 Million
AU$-1.24 Million
≈ $-874.24K
-0.303x +0.21%
2002-06-30 AU$6.32 Million
≈ $4.47 Million
AU$-1.92 Million
≈ $-1.36 Million
-0.304x -36.77%
2001-06-30 AU$7.48 Million
≈ $5.29 Million
AU$-1.66 Million
≈ $-1.17 Million
-0.222x --

About Immuron Ltd

AU:IMC Australia Biotechnology
Market Cap
$9.25 Million
AU$13.07 Million AUD
Market Cap Rank
#27151 Global
#1277 in Australia
Share Price
AU$0.04
Change (1 day)
+0.00%
52-Week Range
AU$0.03 - AU$0.07
All Time High
AU$0.86
About

Immuron Limited, a biopharmaceutical company, engages in the research, development, and commercialization of polyclonal antibodies in Australia, the United States, and Canada. It operates through two segments, Research and Development; and Hyper-immune Products. The company offers Travelan, an over-the-counter medicine to reduce the risk of travelers' diarrhea and risk of minor gastrointestinal d… Read more